Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00511849
Status:
COMPLETED
Last Update Posted:
2010-02-17
First Post:
2007-08-03
Brief Title:
Study Of SU011248 In Combination With PaclitaxelCarboplatin In Patients With Advanced Solid Tumors
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Phase I Study Of SU011248 In Combination With PaclitaxelCarboplatin In Patients With Advanced Solid Malignancies
Status:
COMPLETED
Status Verified Date:
2010-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to test SU011248 sunitinib in combination with paclitaxelcarboplatin This combination regimen will be tested for safety and antitumor activity
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None